StockWatch
·

Lyell Immunopharma, Inc.

Ticker: 1806952

values in millions

Revenue & Profit Trend

in millions
RevenueExpenditureNet Profit
-68.64-21.1626.3373.81Q2 FY24Q3 FY24Q1 FY25Q2 FY25Q3 FY25Q1 FY26Q2 FY26Q3 FY26

Margin Trend

percentage
OPM %NPM %
-102.00-100.67-99.33-98.00Q2 FY24Q3 FY24Q1 FY25Q2 FY25Q3 FY25Q1 FY26Q2 FY26Q3 FY26
PeriodQ3 FY26Q2 FY26Q1 FY26Q3 FY25Q2 FY25Q1 FY25Q3 FY24Q2 FY24
INCOME
Revenue0.000.000.00-100.0%0.02+100.0%0.01+0.0%0.01-66.7%0.03+200.0%0.01
Total Income0.000.000.00-100.0%0.02+100.0%0.01+0.0%0.01-66.7%0.03+200.0%0.01
EXPENSES
Expenditure48.30+2.0%47.34+7.0%44.26+18.8%37.27-21.0%47.15-17.8%57.37+13.5%50.54-1.9%51.54
PROFIT
Net Profit-45.53-1.7%-44.76-85.3%-24.15+37.8%-38.85+9.0%-42.68+18.2%-52.20-17.1%-44.58+2.7%-45.81
KEY METRICS
OPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
NPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
EPS-1.86+3.1%-1.92-74.5%-1.10+48.4%-2.13+26.3%-2.89-1505.6%-0.18-5.9%-0.17+5.6%-0.18